
Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
Keywords: aCSF; artificial cerebrospinal fluid; ANOVA; analysis of variance; BSA; bovine serum albumin; CX3CR1; CX3C-type chemokine receptor 1; GFP; enhanced green fluorescent protein; IL; interleukin; i.p; intraperitoneal; s.c; subcutaneous; LPS; lipopolysaccharid